Clinical Trial 40200


Garden Grove, CA 92845

Study Summary:

A phase II randomised, double-blind, placebo-controlled study to
evaluate the efficacy, safety, and tolerability of orally administered BI
409306 during a 28-week treatment period as adjunctive therapy to
antipsychotic treatment for the prevention of relapse in patients with

Qualified Participants Must:

• Male or female patients
• ICD-10 diagnosis of schizophrenia older than one year prior to randomisation

Qualified Participants May Receive:

Compensation for time and travel

Study is Available At:

CNS Network
12772 Valley View Ave, Suite 3
Garden Grove, CA 92845
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.